Alberta Investment Management Corp Evelo Biosciences, Inc. Transaction History

Alberta Investment Management Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.66 - $6.63 $106,400 - $265,200	-40,000 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$6.07 - $12.0 $242,800 - $480,000	40,000 New	40,000 $243,000
Q3 2021 Nov 15, 2021	SELL	$6.79 - $13.9 $271,600 - $556,000	-40,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$9.43 - $16.6 $377,200 - $664,000	40,000 New	40,000 $550,000

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

Stay updated on Alberta Investment Management Corp with notifications on news.